FDA Approves Angiotech's Pulmonary Embolism Device

The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) sending the stock price soaring 65 cents to $2.35.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.